Abiopharma

🔍 Goldstein Jeffrey A (Executive)

Company: Bank of New York Mellon Corp (BK)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 341 shares of Common Stock at $120.97 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: false | shares_owned_after: 42,308.41 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Phantom stock acquired pursuant to prior election under The Bank of New York Mellon Corporation Deferred Compensation Plan for Directors payable at a specified date in shares of The Bank of New York Mellon Corporation common stock.